CoreWeave vs. D-Wave Quantum: Is the AI Giant or the Quantum Computer Upstart the Better Stock Investment?

As the race for processing power intensifies, investors are looking beyond traditional chipmakers to find the next winners. Choosing between CoreWeave (NASDAQ:CRWV) and D-Wave Quantum (NASDAQ:QBTS) requires weighing two very different architectural futures.

CoreWeave focuses on immediate AI infrastructure needs through GPU-accelerated cloud services, while D-Wave focuses on the long-term potential of quantum annealing and gate-model systems. Both companies represent high-growth, high-risk opportunities within the evolving landscape of global computing demand.

The case for CoreWeave

CoreWeave provides a specialized infrastructure for tech stocks and AI labs, offering a cloud platform purpose-built for training massive AI models. Its strategy centers on providing high-performance computing resources, specifically partnering with Nvidia (NASDAQ:NVDA) to ensure access to critical hardware. In 2025, Microsoft (NASDAQ:MSFT) accounted for approximately 67% of total revenue. Customer concentration like this adds a layer of risk to the business.

In its 2025 fiscal year (FY), revenue reached $5.1 billion, representing a significant 168% increase over the previous year. Despite this massive growth in the top line, the company reported a net loss of $1.2 billion for the same period. This trend reflects the high costs associated with scaling a global data center footprint to meet the demand for AI-driven advantage.

As of its December 2025 balance sheet, the debt-to-equity ratio, which compares total debt to shareholder equity, reached 8.9x. The current ratio, a measure of the company's ability to cover short-term liabilities with short-term assets, was 0.5x. Free cash flow, calculated as operating cash flow minus capital expenditures, was negative $7.3 billion. Note that stock-based compensation represented roughly 20.6% of operating cash flow, which inflates reported cash generation since it is a non-cash expense.

The case for D-Wave Quantum

D-Wave Quantum focuses on delivering quantum computing systems and software services to a diverse group of enterprise and government clients. Its Leap cloud service allows organizations like Mastercard (NYSE:MA), Pfizer (NYSE:PFE), and BASF (OTC:BFFAF) to run quantum-hybrid applications for complex logistics and manufacturing. The company also works with Siemens Healthineers (OTC:SEMHF) and government agencies on national security solutions.

In FY 2025, revenue reached $24.6 million, which is an increase of 179% compared to the prior fiscal year. The company recorded a net loss of $355.1 million during this period as it continued to invest in its dual-platform technology. While the revenue base is still small, the year-over-year growth highlights a steady rise in commercial interest for quantum solutions.

According to its December 2025 balance sheet, D-Wave Quantum maintains a debt-to-equity ratio of 0.1x. Its current ratio, which measures liquidity, was 42.4x, suggesting a robust cushion of short-term assets. Free cash flow for FY 2025 was negative $75.8 million, as the company prioritized research and development over immediate cash generation.

Risk profile comparison

CoreWeave faces significant risks related to its extreme revenue concentration among a small number of top customers, including Microsoft. Operational reliance on a limited number of suppliers for critical components, specifically Nvidia GPUs, creates vulnerability to supply chain disruptions. The business requires massive capital expenditures for data center expansion, and the company is currently navigating several securities class action lawsuits regarding its scaling capabilities.

D-Wave Quantum operates in an early-stage, volatile industry where market adoption and technological feasibility remain unproven. A significant risk factor is its reliance on third-party cloud and manufacturing providers for its hardware delivery. The company has a history of significant net losses and negative cash flows, while also being exposed to currency exchange rate volatility and complex international regulatory requirements regarding quantum technology exports.

Valuation comparison

CoreWeave appears more reasonably valued on a sales basis compared to D-Wave Quantum, though both companies trade at significant premiums reflecting their high growth rates.

Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.

Which stock would I buy in 2026?

Deciding whether to invest in CoreWeave or D-Wave Quantum is a tricky choice because both are high-risk, high-reward stocks. Between the two, I favor CoreWeave for a few reasons.

CoreWeave operates in the hot AI infrastructure sector. The need for data centers to serve as AI factories is so great, the company is experiencing incredible sales growth.

In the second quarter of 2026, revenue hit $2.6 billion, a strong 112% year-over-year increase. It forecasted this year's sales to reach at least $12.4 billion, more than double the $5.1 billion achieved in 2025. On Sept. 17, CoreWeave announced it had added over $25 billion of net new customer commitments as of early Q3.

D-Wave Quantum is still in the early stages of the quantum computing revolution. While it saw 179% year-over-year sales growth in FY 2025, revenue is down in 2026. Through the first half of the year, sales totaled $5.9 million compared to $18.1 million in 2025. Until the company can gain widespread commercial adoption of its technology, its revenue growth is likely to remain volatile.

Given this, combined with CoreWeave's strong sales and superior share price valuation, these factors make CoreWeave the better investment. However, CoreWeave continues to add debt to its balance sheet. On Sept. 18, it announced an upsized $3.7 billion convertible senior note offering. So if sales were to cool off or interest rates continued to rise, its stock is likely fall.

Robert Izquierdo has positions in CoreWeave, Microsoft, Nvidia, and Pfizer. The Motley Fool has positions in and recommends Mastercard, Microsoft, Nvidia, and Pfizer. The Motley Fool has a disclosure policy.